2018 대한부정맥학회 심실빈맥 전극도자 절제술 가이드라인 Part 3

참고문헌 (303)

1. Zipes DP, "Sudden Cardiac Death", Circulation, 98, pp.2334~2351 (1998)
2. Stevenson WG, "Sudden death prevention in patients with advanced ventricular dysfunction", Circulation, 88, pp.2953~2961 (1993)
3. AlJaroudi WA, "Effect of angiotensin-converting enzyme inhibitors and receptor blockers on appropriate implantable cardiac defibrillator shock in patients with severe systolic heart failure (from the GRADE Multicenter Study)", Am J Cardiol, 115, pp.924~931 (2015)
4. Garg R, "Overview of randomized trials of angiotensinconverting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials", JAMA, 273, pp.1450~1456 (1995)
5. Gilstrap LG, "Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors", Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction, 2017, pp.6, e004675~
6. Chatterjee S, "Comparable benefit of beta-blocker therapy in heart failure across regions of the world : meta-analysis of randomized clinical trials", Can J Cardiol, 30, pp.898~903 (2014)
7. Peck KY, "Medical therapy versus implantable cardioverter-defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure : a meta-analysis of > 35, 000 patients", Int J Cardiol, 173, pp.197~203 (2014)
8. Pitt B, "Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure", J Am Coll Cardiol, 46, pp.425~431 (2005)
9. Pitt B, "The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators", N Engl J Med, 341, pp.709~717 (1999)
10. Singh SN, "Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure", N Engl J Med, 333, pp.77~82 (1995)
11. Moss AJ, "Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction", N Engl J Med, 346, pp.877~883 (2002)
12. Bardy GH, "Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure", N Engl J Med, 352, pp.225~237 (2005)
13. Kadish A, "Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy", N Engl J Med, 350, pp.2151~2158 (2004)
14. Bristow MR, "Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure", N Engl J Med, 350, pp.2140~2150 (2004)
15. Maggioni AP, "Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results", Circulation, 87, pp.312~322 (1993)
16. Baman TS, "Relationship between burden of premature ventricular complexes and left ventricular function", Heart Rhythm, 7, pp.865~869 (2010)
17. Ban JE, "Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease", Europace, 15, pp.735~741 (2013)
18. Bogun F, "Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention", Heart Rhythm, 4, pp.863~867 (2007)
19. Carballeira Pol L, "Ventricular premature depolarization QRS duration as a new marker of risk for the development of ventricular prematuredepolarization-induced cardiomyopathy", Heart Rhythm, 11, pp.299~306 (2014)
20. Deyell MW, "Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations", Heart Rhythm, 9, pp.1465~1472 (2012)
21. Hasdemir C, "Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias : the incidence, clinical and electrophysiologic characteristics, and the predictors", J Cardiovasc Electrophysiol, 22, pp.663~668 (2011)
22. Hamon D, "A New Combined Parameter to Predict Premature Ventricular Complexes Induced Cardiomyopathy : Impact and Recognition of Epicardial Origin", J Cardiovasc Electrophysiol, 27, pp.709~717 (2016)
23. Hasdemir C, "Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias : the incidence, clinical and electrophysiologic characteristics, and the predictors", J Cardiovasc Electrophysiol, 22, pp.663~668 (2011)
24. Niwano S, "Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function", Heart, 95, pp.1230~1237 (2009)
25. Haïssaguerre M, "Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation", Lancet, 359, pp.677~678 (2002)
26. Haïssaguerre M, "Mapping and ablation of idiopathic ventricular fibrillation", Circulation, 106, pp.962~967 (2002)
27. Al-Khatib SM, "2017 AHA", ACC, American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, pp.Heart Rhythm, 2017
28. Bardy GH, "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure", N Engl J Med, 352, pp.225~237 (2005)
29. Lee GK, "Premature ventricular contraction-induced cardiomyopathy : a treatable condition", Circ Arrhythm Electrophysiol, 5, pp.229~236 (2012)
30. Singh SN, "Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure", N Engl J Med, 333, pp.77~82 (1995)
31. Steg PG, "Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction : the USIC 2000 registry", Heart, 92, pp.1378~1383 (2006)
32. Weisfeldt ML, "Survival after application of automatic external defibrillators before arrival of the emergency medical system : evaluation in the resuscitation outcomes consortium population of 21 million", J Am Coll Cardiol, 55, pp.1713~1720 (2010)
33. Nolan JP, "European Resuscitation Council Guidelines for Resuscitation 2010Section 1. Executive summary", Resuscitation, 81, pp.1219~1276 (2010)
34. Søholm H, "Tertiary centres have improved survival compared to other hospitals in the Copenhagen area after out-of-hospital cardiac arrest", Resuscitation, 84, pp.162~167 (2013)
35. Xiao G, "Safety profile and outcome of mild therapeutic hypothermia in patients following cardiac arrest : systematic review and meta-analysis", Emerg Med J, 30, pp.91~100 (2013)
36. Boersma E, "Early thrombolytic treatment in acute myocardial infarction : reappraisal of the golden hour", Lancet, 348, pp.771~775 (1996)
37. Boersma E, "Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients", Eur Heart J, 27, pp.779~788 (2006)
38. Keeley EC, "Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction : quantitative review of randomised trials", Lancet, 367, pp.579~588 (2006)
39. Windecker S, "2014 ESC", EACTS Guidelines on myocardial revascularization : The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI), 2014, pp.35, 2541~2619
40. Roffi M, "2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation : Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiolog y(ESC)", Eur Heart J, 37, pp.267~315 (2016)
41. Spaulding CM, "Immediate coronary angiography in survivors of out-of-hospital cardiac arrest", N Engl J Med, 336, pp.1629~1633 (1997)
42. Dumas F, "Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest : insights from the PROCAT(Parisian Region Out of hospital Cardiac ArresT)registry", Circ Cardiovasc Interv, 3, pp.200~207 (2010)
43. Bowers TR, "Effect of reperfusion on biventricular function and survival after right ventricular infarction", N Engl J Med, 338, pp.933~940 (1998)
44. Reddy YM, "Percutaneous left ventricular assist devices in ventriculartachycardia ablation : multicenter experience", Circ Arrhythm Electrophysiol, 7, pp.244~250 (2014)
45. Lamhaut L, "Safety and feasibility of prehospital extracorporeal life support implementation by non-surgeons for out-of-hospital refractory cardiac arrest", Resuscitation, 84, pp.1525~1529 (2013)
46. Wang CH, "Improved outcome of extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest--a comparison with that for extracorporeal rescue for in-hospital cardiac arrest", Resuscitation, 85, pp.1219~1224 (2014)
47. Registry), "Am J Cardiol", 2008, 1427~1432
48. Wolfe CL, "Polymorphous ventricular tachycardia associated with acute myocardial infarction", Circulation, 84, pp.1543~1551 (1991)
49. Zafari AM, "A program encouraging early defibrillation results in improved in-hospital resuscitation efficacy", J Am Coll Cardiol, 44, pp.846~852 (2004)
50. Nolan JP, "European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary", Resuscitation, 81, pp.1219~1276 (2010)
51. Kontos MC, "Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®)", Am Heart J, 161, pp.864~870 (2011)
52. Chatterjee S, "Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials", Int J Cardiol, 168, pp.915~921 (2013)
53. Bangalore S, "Clinical outcomes with β-blockers for myocardial infarction : a meta-analysis of randomized trials", Am J Med, 127, pp.939~953 (2014)
54. Enjoji Y, "Catheter ablation of fatal ventricular tachyarrhythmias storm in acute coronary syndrome--role of Purkinje fiber network", J Interv Card Electrophysiol, 26, pp.207~215 (2009)
55. Frankel DS, "Ventricular tachycardia ablation remains treatment of last resort in structural heart disease : argument for earlier intervention", J Cardiovasc Electrophysiol, 22, pp.1123~1128 (2011)
56. Peichl P, "Catheter ablation of arrhythmic storm triggered by monomorphic ectopic beats in patients with coronary artery disease", J Interv Card Electrophysiol, 27, pp.51~59 (2010)
57. Deneke T, "Catheter ablation of electrical storm", Expert Rev Cardiovasc Ther, 9, pp.1051~1058 (2011)
58. Deneke T, "Catheter ablation of electrical storm in a collaborative hospital network", Am J Cardiol, 108, pp.233~239 (2011)
59. Gorenek B, "Cardiac arrhythmias in acute coronary syndromes : position paper from the joint EHRA, ACCA, and EAPCI task force", Europace, 16, pp.1655~1673 (2014)
60. Shaw DJ, "Multidisciplinary team training to enhance family communication in the ICU", Crit Care Med, 42, pp.265~271 (2014)
61. Piccini JP, "Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction", Crit Care Med, 39, pp.78~83 (2011)
62. Huikuri HV, "Sudden death due to cardiac arrhythmias", N Engl J Med, 345, pp.1473~1482 (2001)
63. Hine LK, "Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction", Arch Intern Med, 149, pp.2694~2698 (1989)
64. Ibanez B, "2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation : The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)", Eur Heart J, 39, pp.119~177 (2018)
65. Borne RT, "Implantable cardioverterdefibrillator shocks : epidemiology, outcomes, and therapeutic approaches", JAMA Intern Med, 173, pp.859~865 (2013)
66. Liang JJ, "Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?", Europace, 16, pp.1759~1766 (2014)
67. Hohnloser SH, "Prophylactic use of an implantable cardioverterdefibrillator after acute myocardial infarction", N Engl J Med, 351, pp.2481~2488 (2004)
68. Steinbeck G, "Defibrillator implantation early after myocardial infarction", N Engl J Med, 361, pp.1427~1436 (2009)
69. Epstein AE, "Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction", J Am Coll Cardiol, 62, pp.2000~2007 (2013)
70. Wilkoff BL, "2015 HRS", EHRA, SOLAECE expert consensus statement on optimal implantable cardioverterdefibri l lator programming and testing, pp.Heart Rhythm, 2016[DOI]
71. "2015 Korean Guidelines for cardiopulmonary resuscitation and emergency cardiovascular carea"[URL]
72. Zipes DP, "ACC", AHA, American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society, pp.Eur Heart J, 2006[DOI]
73. Aliot EM, "EHRA", HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias : developed in a partnership with the European Heart Rhythm Association(EHRA), a Registered Branch of the European Society of Cardiology(ESC), and the Heart Rhythm Society(HRS); in collaboration with the American College of Cardiology(ACC)and the American Heart Association(AHA), 2009, pp.11, 771~817
74. Brignole M, "2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)", Eur Heart J, 34, pp.2281~2329 (2013)
75. Bougouin W, "Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction : a 5-year cause-of-death analysis of the FAST-MI 2005 registry", Eur Heart J, 35, pp.116~122 (2014)
76. Avezum A, "Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes (from the GRACE Registry)", Am J Cardiol, 102, pp.1577~1582 (2008)
77. Piccini JP, "Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes", Circulation, 126, pp.41~49 (2012)
78. Dorian P, "Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation", N Engl J Med, 346, pp.884~890 (2002)
79. Scheinman MM, "Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Mul ticenter Investi g ators Group", Circulation, 92, pp.3264~3272 (1995)
80. Kowey PR, "Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group", Circulation, 92, pp.3255~3263 (1995)
81. Bänsch D, "Successful catheter ablation of electrical storm after myocardial infarction", Circulation, 108, pp.3011~3016 (2003)
82. Buxton AE, "Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators", N Engl J Med, 342, pp.1937~1945 (2000)
83. Buxton AE, "Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease : lessons from the MUSTT study", J Am Coll Cardiol, 50, pp.1150~1157 (2007)
84. Gatzoulis KA, "Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function", Int J Cardiol, 176, pp.1449~1451 (2014)
85. Exner DV, "Noninvasive risk assessment early after a myocardial infarction the REFINE study", J Am Coll Cardiol, 50, pp.2275~2284 (2007)
86. Malik M, "Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone : a substudy of EMIAT(The European Myocardial Infarct Amiodarone Trial)", J Am Coll Cardiol, 35, pp.1263~1275 (2000)
87. Søholm H, "Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention--is it necessary", Eur Heart J Acute Cardiovasc Care, 4, pp.528~536 (2015)
88. Allman KC, "Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction : a meta-analysis", J Am Coll Cardiol, 39, pp.1151~1158 (2002)
89. St John Sutton M, "Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril", Circulation, 89, pp.68~75 (1994)
90. Hohnloser SH, "Prophylactic use of an implantable cardioverterdefibrillator after acute myocardial infarction", N Engl J Med, 351, pp.2481~2488 (2004)
91. Steinbeck G, "Defibrillator implantation early after myocardial infarction", N Engl J Med, 361, pp.1427~1436 (2009)
92. Zaman S, "Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction", Circulation, 129, pp.848~854 (2014)
93. Ibanez B, "2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation : The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)", Eur Heart J, 39, pp.119~177 (2018)
94. Buxton AE, "Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators", N Engl J Med, 342, pp.1937~1945 (2000)
95. Buxton AE, "Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease : lessons from the MUSTT study", J Am Coll Cardiol, 50, pp.1150~1157 (2007)
96. Gatzoulis KA, "Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function", Int J Cardiol, 176, pp.1449~1451 (2014)
97. Kelly P, "Surgical coronary revascularization in survivors of prehospital cardiac arrest : its effecton inducible ventricular arrhythmias and long-term survival", J Am Coll Cardiol, 15, pp.267~273 (1990)
98. van der Burg AE, "Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death", Circulation, 108, pp.1954~1959 (2003)
99. Steinberg JS, "New-onset sustained ventricular tachycardia af t er cardiac surg er y", Circulation, 99, pp.903~908 (1999)
100. Brugada J, "Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction : effects on the electrophysiologic substrate and outcome", J Am Coll Cardiol, 37, pp.529~533 (2001)
101. Windecker S, "2014 ESC", EACTS Guidelines on myocardial revascularization : The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI), 2014, pp.35, 2541~2619
102. Bigger JT Jr, "Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronaryartery bypass graft surgery. Coronary Artery Bypass Graft (CABG)Patch Trial Investigators", N Engl J Med, 337, pp.1569~1575 (1997)
103. Bax JJ, "Time course of functional recovery of stunned and hibernating segments after surgical revascularization", Circulation, 104, pp.I314~I318 (2001)
104. Funaro S, "Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention : results of the Acute Myocardial Infarction Contrast Imaging(AMICI)multicenter study", Eur Heart J, 30, pp.566~575 (2009)
105. Søholm H, "Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention--is it necessary", Eur Heart J Acute Cardiovasc Care, 4, pp.528~536 (2015)
106. Cairns JA, "Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators", Lancet, 349, pp.675~682 (1997)
107. Julian DG, "Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators", Lancet, 349, pp.667~674 (1997)
108. Cardiac Arrhythmia Suppression Trial (CAST) Investigators, "Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction", N Engl J Med, 321, pp.406~412 (1989)
109. Echt DS, "Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial", N Engl J Med, 324, pp.781~788 (1991)
110. Deneke T, "Catheter ablation of electrical storm", Expert Rev Cardiovasc Ther, 9, pp.1051~1058 (2011)
111. Koenig S, "Catheter ablation of ventricular tachycardia in the setting of electrical storm after revascularization of a chronic total occlusion of the right coronary artery : An uncommon presentation of reperfusion arrhythmia", HeartRhythm Case Rep, 2, pp.462~464 (2016)
112. Frankel DS, "Ventricular tachycardia ablation remains treatment of last resort in structural heart disease : argument for earlier intervention", J Cardiovasc Electrophysiol, 22, pp.1123~1128 (2011)
113. Enjoji Y, "Catheter ablation of fatal ventricular tachyarrhythmias storm in acute coronary syndrome--role of Purkinje fiber network", J Interv Card Electrophysiol, 26, pp.207~215 (2009)
114. Peichl P, "Catheter ablation of arrhythmic storm triggered by monomorphic ectopic beats in patients with coronary artery disease", J Interv Card Electrophysiol, 27, pp.51~59 (2010)
115. Deneke T, "Catheter ablation of electrical storm in a collaborative hospital network", Am J Cardiol, 108, pp.233~239 (2011)
116. Connolly SJ, "Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial", JAMA, 295, pp.165~171 (2006)
117. Pacifico A, "Prevention of implantable-defibrillator shocks by treatment with sotalol.d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group", N Engl J Med, 340, pp.1855~1862 (1999)
118. Kettering K, "Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator", Pacing Clin Electrophysiol, 25, pp.1571~1576 (2002)
119. Sapp JL, "Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs", N Engl J Med, 375, pp.111~121 (2016)
120. Mallidi J, "Metaanalysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease", Heart Rhythm, 8, pp.503~510 (2011)
121. Calkins H, "Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group", J Am Coll Cardiol, 35, pp.1905~1914 (2000)
122. Stevenson WG, "Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial", Circulation, 118, pp.2773~2782 (2008)
123. Tanner H, "Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology : results of the prospective multicenter Euro-VT-study", J Cardiovasc Electrophysiol, 21, pp.47~53 (2010)
124. Marchlinski FE, "Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia : Post-Approval THERMOCOOL VT Trial", J Am Coll Cardiol, 67, pp.674~683 (2016)
125. Tung R, "Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study", Heart Rhythm, 12, pp.1997~2007 (2015)
126. Al-Khatib SM, "Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator(CALYPSO)pilot trial", J Cardiovasc Electrophysiol, 26, pp.151~157 (2015)
127. Kuck KH, "Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease(VTACH) : a multicentre randomised controlled trial", Lancet, 375, pp.31~40 (2010)
128. Sesselberg HW, "Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications : a MADIT-II substudy", Heart Rhythm, 4, pp.1395~1402 (2007)
129. Carbucicchio C, "Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators : short-and long-term outcomes in a prospective single-center study", Circulation, 117, pp.462~469 (2008)
130. Szumowski L, "Mapping and ablation of polymorphic ventricular tachycardia after myocardial infarction", J Am Coll Cardiol, 44, pp.1700~1706 (2004)
131. Marrouche NF, "Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy", J Am Coll Cardiol, 43, pp.1715~1720 (2004)
132. Peichl P, "Catheter ablation of arrhythmic storm triggered by monomorphic ectopic beats in patients with coronary artery disease", J Interv Card Electrophysiol, 27, pp.51~59 (2010)
133. Park KM, "Recurrent polymorphic ventricular tachycardia treated by ablation of Purkinje arborization within an infarct border-zone", Tex Heart Inst J, 38, pp.291~294 (2011)
134. Echt DS, "Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial", N Engl J Med, 324, pp.781~788 (1991)
135. Sears SF Jr, "Examining the psychosocial impact of implantable cardioverter defibrillators : a literature review", Clin Cardiol, 22, pp.481~489 (1999)
136. Aliot EM, "EHRA", HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias : developed in a partnership with the European Heart Rhythm Association(EHRA), a Registered Branch of the European Society of Cardiology(ESC), and the Heart Rhythm Society(HRS); in collaboration with the American College of Cardiology(ACC)and the American Heart Association(AHA), 2009, pp.6, 886~933
137. Claro JC, "Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death", Cochrane Database Syst Rev, (12), pp.CD008093~ (2015)
138. Bunch TJ, "Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks", Pacing Clin Electrophysiol, 34, pp.1600~1606 (2011)
139. Goldschlager N, "A practical guide for clinicians who treat patients with amiodarone : 2007", Heart Rhythm, 49, pp.1250~1259 (2007)
140. Kim YH, "Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease", Circulation, 89, pp.1094~1102 (1994)
141. Stevenson WG, "Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction", Circulation, 98, pp.308~314 (1998)
142. Nakagawa H, "Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation", Circulation, 91, pp.2264~2273 (1995)
143. Soejima K, "Saline-cooled versus standard radiofrequency catheter ablation for infarct-related ventricular tachycardias", Circulation, 103, pp.1858~1862 (2001)
144. Kowey PR, "An overview of antiarrhythmic drug management of electrical storm", Can J Cardiol, 12(Suppl B), pp.3B~8B (1996)
145. Credner SC, "Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications", J Am Coll Cardiol, 32, pp.1909~1915 (1998)
146. Exner DV, "Electrical storm presages nonsudden death : the antiarrhythmics versus implantable defibril lators(AVID)tria l", Circulation, 103, pp.2066~2071 (2001)
147. Guerra F, "Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors : a meta-analysis", Europace, 16, pp.347~353 (2014)
148. Poole JE, "Prognostic importance of defibrillator shocks in patients with heart failure", N Engl J Med, 359, pp.1009~1017 (2008)
149. Reddy VY, "Prophylactic catheter ablation for the prevention of defibrillator therapy", N Engl J Med, 357, pp.2657~2665 (2007)
150. Kuck KH, "Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study)", Circ Arrhythm Electrophysiol, 10, pp.e004422~ (2017)
151. Schwartz PJ, "Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions", J Cardiovasc Electrophysiol, 3, pp.2~16 (1992)
152. Vaseghi M, "Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm : intermediate and long-term follow-up", Heart Rhythm, 11, pp.360~366 (2014)
153. Vaseghi M, "Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias", J Am Coll Cardiol, 69, pp.3070~3080 (2017)
154. Raitt MH, "Stable"ventricular tachycardia is not a benign rhythm : insights from the antiarrhythmics versus implantable defibrillators(AVID)registry", Circulation, 103, pp.244~252 (2001)
155. Pauriah M, "A stepwise approach to the management of postinfarct ventricular tachycardia using catheter ablation as the first-line treatment : a single-center experience", Circ Arrhythm Electrophysiol, 6, pp.351~356 (2013)
156. Maury P, "Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%", Eur Heart J, 35, pp.1479~1485 (2014)
157. 김준, "Catheter Ablation of Ventricular Arrhythmias via the Radial Artery in a Patient With Prior Myocardial Infarction and Peripheral Vascular Disease", Korean Circulation Journal, 42(9), pp.632~637 (2012), 대한심장학회
158. 김민석, "Korean Guidelines for Diagnosis and Management of Chronic Heart Failure", Korean Circulation Journal, 47(5), pp.555~643 (2017), 대한심장학회[DOI]
159. Connolly SJ, "Canadian implantable defibrillator study(CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone", Circulation, 101, pp.1297~1302 (2000)
160. Kuck KH, "Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg(CASH)", Circulation, 102, pp.748~754 (2000)
161. The Antiarrhythmics versus Implantable Defibrillators(AVID)Investigators, "A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias", N Engl J Med, 337, pp.1576~1583 (1997)
162. Desai AS, "Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: ameta-analysis of randomized controlled trials", JAMA, 15(292), pp.2874~2879 (2004)
163. Bänsch D, "Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy : the Cardiomyopathy Trial(CAT)", Circulation, 105, pp.1453~1458 (2002)
164. Kadish A, "Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy", N Engl J Med, 350, pp.2151~2158 (2004)
165. Bristow MR, "Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure", N Engl J Med, 350, pp.2140~2150 (2004)
166. Strickberger SA, "Amiodarone versus implantable cardioverter-defibrillator : randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia—AMIOVIRT", J Am Coll Cardiol, 41, pp.1707~1712 (2003)
167. Bardy GH, "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure", N Engl J Med, 352, pp.225~237 (2005)
168. van Rijsingen IA, "Risk factors for malignant ventricular arrhythmias in lamin a", c mutation carriers a European cohort study, 2012, pp.59, 493~500
169. Braunschweig F, "Management of patients receiving implantable cardiac defibrillator shocks : recommendations for acute and long-term patient management", Europace, 12, pp.1673~1690 (2010)
170. Wilkoff BL, "2015 HRS", EHRA, SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing, pp.Heart Rhythm, 2016[DOI]
171. Proietti R, "Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease : effect of cardiomyopathy type and acute success on long-term outcome", Europace, 17, pp.461~467 (2015)
172. Goldberger JJ, "Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy", J Am Coll Cardiol, 63, pp.1879~1889 (2014)
173. Cardiac Arrhythmia Suppression Trial(CAST)Investigators, "Preliminary report : effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction", N Engl J Med, 321, pp.406~412 (1989)
174. Kober L, "Increased mortality after dronedarone therapy for severe heart failure", N Engl J Med, 358, pp.2678~2687 (2008)
175. Connolly SJ, "Dronedarone in high-risk permanent atrial fibrillation", N Engl J Med, 365, pp.2268~2276 (2011)
176. Raitt MH, "Stable ventricular tachycardia is not a benign rhythm : insights from the antiarrhythmics versus implantable defibrillators(AVID)registry", Circulation, 103, pp.244~252 (2001)
177. Køber L, "Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure", N Engl J Med, 375, pp.1221~1230 (2016)
178. Golwala H, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy : An Updated Meta-Analysis", Circulation, 135, pp.201~203 (2017)
179. Beggs SAS, "Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators : a review and meta-analysis", Heart, 104, pp.144~150 (2018)
180. Haas J, "Atlas of the clinical genetics of human dilated cardiomyopathy", Eur Heart J, 36, pp.1123~1135a (2015)
181. Blanck Z, "Bundle branch reentrant ventricular tachycardia : cumulative experience in 48 patients", J Cardiovasc Electrophysiol, 4, pp.253~262 (1993)
182. Caceres J, "Sustained bundle branch reentry as a mechanism of clinical tachycardia", Circulation, 79, pp.256~270 (1989)
183. Kottkamp H, "Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy", Circulation, 92, pp.1159~1168 (1995)
184. Hsia HH, "Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia", Circulation, 108, pp.704~710 (2003)
185. Soejima K, "Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy : the importance of low-voltage scars", J Am Coll Cardiol, 43, pp.1834~1842 (2004)
186. Cano O, "Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy", J Am Coll Cardiol, 54, pp.799~808 (2009)
187. Oloriz T, "Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy : anteroseptal versus inferolateral scar sub-types", Circ Arrhythm Electrophysiol, 7, pp.414~423 (2014)
188. Piers SR, "Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility", Circ Arrhythm Electrophysiol, 6, pp.513~521 (2013)
189. Dinov B, "Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy : results from the Prospective Heart Centre of Leipzig VT(HELP-VT)Study", Circulation, 129, pp.728~736 (2014)
190. Dinov B, "Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality", Circ Arrhythm Electrophysiol, 8, pp.598~605 (2015)
191. Muser D, "Long-Term Outcome After CatheterAblation of Ventricular Tachycardia in Patients With Nonischemic Dilated Cardiomyopathy", Circ Arrhythm Electrophysiol, 9, pp.e004328~ (2016)
192. Arya A, "Catheter ablation of electrical storm due to monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy : acute results and its effect on long-term survival", Pacing Clin Electrophysiol, 33, pp.1504~1509 (2010)
193. Elliott PM, "2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy : the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology(ESC)", Eur Heart J, 35, pp.2733~2779 (2014)
194. O'Mahony C, "A validation study of the 2003American College of Cardiology", European Society of Cardiology and 2011 American College of Cardiology Foundation, Heart, pp.2013, 99[DOI]
195. O'Mahony C, "The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy", Heart, 98, pp.116~125 (2012)
196. Elliott PM, "Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy", J Am Coll Cardiol, 33, pp.1596~1601 (1999)
197. Cecchi F, "Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest", J Am Coll Cardiol, 13, pp.1283~1288 (1989)
198. Maron BJ, "Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy", JAMA, 298, pp.405~412 (2007)
199. Syska P, "Implantable cardioverterdefibrillator in patients with hypertrophic cardiomyopathy : efficacy and complications of the therapy in long-term follow-up", J Cardiovasc Electrophysiol, 21, pp.883~889 (2010)
200. O'Mahony C, "A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy(HCM risk-SCD)", Eur Heart J, 35, pp.2010~2020 (2014)
201. Elliott PM, "Sudden death in hypertrophic cardiomyopathy : identification of high risk patients", J Am Coll Cardiol, 36, pp.2212~2218 (2000)
202. Spirito P, "Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy", N Engl J Med, 342, pp.1778~1785 (2000)
203. Elliott PM, "Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy", Lancet, 357, pp.420~424 (2001)
204. Sorajja P, "Use of echocardiography in patients with hypertrophic cardiomyopathy : clinical implications of massive hypertrophy", J Am Soc Echocardiogr, 19, pp.788~795 (2006)
205. Bos JM, "Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy", Am J Cardiol, 106, pp.1481~1486 (2010)
206. Maron BJ, "Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy", N Engl J Med, 342, pp.365~373 (2000)
207. Spirito P, "Syncope and risk of sudden death in hypertrophic cardiomyopathy", Circulation, 119, pp.1703~1710 (2009)
208. Monserrat L, "Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy : an independent marker of sudden death risk in young patients", J Am Coll Cardiol, 42, pp.873~879 (2003)
209. Maki S, "Predictors of sudden cardiac death in hypertrophic cardiomyopathy", Am J Cardiol, 82, pp.774~778 (1998)
210. Olivotto I, "Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy", J Am Coll Cardiol, 33, pp.2044~2051 (1999)
211. Sadoul N, "Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy", Circulation, 96, pp.2987~2991 (1997)
212. McKenna WJ, "Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia", Br Heart J, 53, pp.412~416 (1985)
213. Melacini P, "Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy", Heart, 93, pp.708~710 (2007)
214. Santangeli P, "Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy : safety and feasibility", Heart Rhythm, 7, pp.1036~1042 (2010)
215. Inada K, "Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy", J Cardiovasc Electrophysiol, 22, pp.41~48 (2011)
216. Dukkipati SR, "Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy", Circ Arrhythm Electrophysiol, 4, pp.185~194 (2011)
217. Rowin EJ, "Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm : Implications for Risk Stratification and Management", J Am Coll Cardiol, 69, pp.761~773 (2017)
218. Kuck KH, "Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope", Eur Heart J, 9, pp.177~185 (1988)
219. Zhu DW, "The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy", Pacing Clin Electrophysiol, 21, pp.299~302 (1998)
220. Maron BJ, "Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy", Am J Cardiol, 116, pp.757~764 (2015)
221. Vriesendorp PA, "Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy", Circ Arrhythm Electrophysiol, 8, pp.829~835 (2015)
222. Bhonsale A, "Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia", cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention, 2011, pp.58, 1485~1496
223. Corrado D, "Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy", dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia, 2010, pp.122, 1144~1152
224. Corrado D, "Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy", Dysplasia : An International Task Force Consensus Statement, 2015, pp.132, 441~453
225. Link MS, "Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment", J Am Coll Cardiol, 64, pp.119~125 (2014)
226. Piccini JP, "Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia", Heart Rhythm, 2, pp.1188~1194 (2005)
227. Marcus FI, "Arrhythmogenic right ventricular cardiomyopathy", dysplasia clinical presentation and diagnostic evaluation : results from the North American Multidisciplinary Study, 2009, pp.6, 984~992
228. Marcus GM, "Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy : a report from the North American ARVC Registry", J Am Coll Cardiol, 54, pp.609~615 (2009)
229. Dalal D, "Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia", cardiomyopathy, 2007, pp.50, 432~440
230. Garcia FC, "Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy", dysplasia, 2009, pp.120, 366~375
231. Bai R, "Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia", cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation, 2011, pp.4, 478~485
232. Philips B, "Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia", cardiomyopathy, 2012, pp.5, 499~505
233. Berruezo A, "Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique", Circ Arrhythm Electrophysiol, 5, pp.111~121 (2012)
234. Philips B, "Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia", cardiomyopathy, 2015, pp.12, 716~725
235. Santangeli P, "Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy", Circ Arrhythm Electrophysiol, 8, pp.1413~1421 (2015)
236. Saguner AM, "Usefulness of inducible ventricular tachycardia to predict longterm adverse outcomes in arrhythmogenic right ventricular cardiomyopathy", Am J Cardiol, 111, pp.250~257 (2013)
237. Roguin A, "Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia", cardiomyopathy, 2004, pp.43, 1843~1852
238. Corrado D, "Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy", dysplasia : a multicenter study, 1997, pp.30, 1512~1520
239. Dalal D, "Arrhythmogenic right ventricular dysplasia : a United States experience", Circulation, 112, pp.3823~3832 (2005)
240. Wichter T, "Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography", Circulation, 101, pp.1552~1558 (2000)
241. Marcus FI, "Long-term follow-up in patients with arrhythmogenic right ventricular disease", Eur Heart J, 10(Suppl D), pp.68~73 (1989)
242. Orgeron GM, "Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia", Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications, 2017, pp.6, e006242~
243. Reithmann C, "Electroanatomic mapping of endocardial right ventricular activation as a guide for catheter ablation in patients with arrhythmogenic right ventricular dysplasia", Pacing Clin Electrophysiol, 26, pp.1308~1316 (2003)
244. Marchlinski FE, "Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy", Circulation, 110, pp.2293~2298 (2004)
245. Verma A, "Short-and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia", Circulation, 111, pp.3209~3216 (2005)
246. Satomi K, "Catheter ablation of stable and unstable ventricular tachycardias in patients with arrhythmogenic right ventricular dysplasia", J Cardiovasc Electrophysiol, 17, pp.469~476 (2006)
247. Nogami A, "Changes in the isolated delayed component as an endpoint of catheter ablation in arrhythmogenic right ventricular cardiomyopathy : predictor for long-term success", J Cardiovasc Electrophysiol, 19, pp.681~688 (2008)
248. Caforio AL, "Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis : a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases", Eur Heart J, 34, pp.2636~2648 (2013)
249. JCS Joint Working Group, "Guidelines for diagnosis and treatment of myocarditis(JCS 2009) : digest version", Circ J, 75, pp.734~743 (2011)
250. Aoyama N, "National survey of fulminant myocarditis in Japan : therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis(special report from a scientific committee)", Circ J, 66, pp.133~144 (2002)
251. Jung SY, "Extracorporeal life support can be a first-line treatment in children with acute fulminant myocarditis", Interact Cardiovasc Thorac Surg, 23, pp.247~252 (2016)
252. Abe T, "Clinical characteristics and long-term outcome of acute myocarditis in children", Heart Vessels, 28, pp.632~638 (2013)
253. Kindermann I, "Predictors of outcome in patients with suspected myocarditis", Circulation, 118, pp.639~648 (2008)
254. Ponikowski P, "2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure : The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC", Eur Heart J, 37, pp.2129~2200 (2016)
255. Prochnau D, "Successful use of a wearable cardioverterdefibrillator in myocarditis with normal ejection fraction", Clin Res Cardiol, 99, pp.129~131 (2010)
256. Wäßnig NK, "Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death", Circulation, 134, pp.635~643 (2016)
257. Chung MK, "The role of the wearable cardioverter defibrillator in clinical practice", Cardiol Clin, 32, pp.253~270 (2014)
258. Kandolin R, "Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression", Circ Heart Fail, 6, pp.15~22 (2013)
259. Youn JC, "Detailed pathologic evaluation on endomyocardial biopsy provides long-term prognostic information in patients with acute myocarditis", Cardiovasc Pathol, 23, pp.139~144 (2014)
260. Schumm J, "Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis", J Cardiovasc Magn Reson, 16, pp.14~ (2014)
261. Richardson P, "Report of the 1995 World Health Organization", International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies, 1996, pp.93, 841~842
262. Ukena C, "Prognostic electrocardiographic parameters in patients with suspected myocarditis", Eur J Heart Fail, 13, pp.398~405 (2011)
263. Kohno K, "Resuscitation from fulminant myocarditis associated with refractory ventricular fibrillation", Jpn Circ J, 64, pp.139~143 (2000)
264. McCarthy RE 3rd, "Long-term outcome of fulminant myocarditis as compared with acute(nonfulminant)myocarditis", N Engl J Med, 342, pp.690~695 (2000)
265. D'Ambrosio A, "The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy : a review", Heart, 85, pp.499~504 (2001)
266. Kühl U, "Viral persistence in the myocardium is associated with progressive cardiac dysfunction", Circulation, 112, pp.1965~1970 (2005)
267. Mazzone P, "Epicardial management of myocarditis-related ventricular tachycardia", Eur Heart J, 34, pp.244~ (2013)
268. Yazaki Y, "Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone", Am J Cardiol, 88, pp.1006~1010 (2001)
269. Kandolin R, "Cardiac sarcoidosis : epidemiology, characteristics, and outcome over 25 years in a nationwide study", Circulation, 131, pp.624~632 (2015)
270. Kron J, "Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis", Europace, 15, pp.347~354 (2013)
271. Mohsen A, "Cardiac sarcoidosis : electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverterdefibrillator", J Cardiovasc Electrophysiol, 25, pp.171~176 (2014)
272. Schuller JL, "Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis", J Cardiovasc Electrophysiol, 23, pp.925~929 (2012)
273. Coleman GC, "Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis", JACC Cardiovasc Imaging, 10, pp.411~420 (2017)
274. Murtagh G, "Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance", Circ Cardiovasc Imaging, 9, pp.e003738~ (2016)
275. Crawford T, "Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias", Circ Arrhythm Electrophysiol, 7, pp.1109~1115 (2014)
276. Greulich S, "CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis", JACC Cardiovasc Imaging, 6, pp.501~511 (2013)
277. Blankstein R, "Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis", J Am Coll Cardiol, 63, pp.329~336 (2014)
278. Aizer A, "Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis", Am J Cardiol, 96, pp.276~282 (2005)
279. Mehta D, "Primary prevention of sudden cardiac death in silent cardiac sarcoidosis : role of programmed ventricular stimulation", Circ Arrhythm Electrophysiol, 4, pp.43~48 (2011)
280. Takaya Y, "Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis", Am J Cardiol, 115, pp.505~509 (2015)
281. Naruse Y, "Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis", Circ Arrhythm Electrophysiol, 7, pp.407~413 (2014)
282. Segawa M, "Time Course and Factors Correlating With Ventricular Tachyarrhythmias After Introduction of Steroid Therapy in Cardiac Sarcoidosis", Circ Arrhythm Electrophysiol, 9 (2016)
283. Yodogawa K, "Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis", Ann Noninvasive Electrocardiol, 16, pp.140~147 (2011)
284. Koplan BA, "Refractory ventricular tachycardia secondary to cardiac sarcoid : electrophysiologic characteristics, mapping, and ablation", Heart Rhythm, 3, pp.924~929 (2006)
285. Jefic D, "Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis : report from a multicenter registry", Heart Rhythm, 6, pp.189~195 (2009)
286. Rosenheck S, "Therapy success and survival in patients with valvular heart disease and implantable cardioverter defibrillator", Int J Cardiol, 144, pp.103~104 (2010)
287. Yang F, "ICD implantation and arrhythmia-free survival in patients with depressed LV function following surgery for valvular heart disease", Pacing Clin Electrophysiol, 31, pp.1419~1424 (2008)
288. Valles AG, "Implantable cardioverter defibrillators in patients with valvular cardiomyopathy", J Cardiovasc Electrophysiol, 23, pp.1326~1332 (2012)
289. Aranki SF, "Aortic valve endocarditis. Determinants of early survival and late morbidity", Circulation, 90, pp.II175~II182 (1994)
290. Johnson LL, "Reduced left ventricular myocardial blood flow per unit mass in aortic stenosis", Circulation, 57, pp.582~590 (1978)
291. Martínez-Rubio A, "Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope : results of programmed ventricular stimulation and long-term follow-up", Circulation, 96, pp.500~508 (1997)
292. Narasimhan C, "Ventricular tachycardia in valvular heart disease : facilitation of sustained bundle-branch reentry by valve surgery", Circulation, 96, pp.4307~4313 (1997)
293. von Olshausen K, "Determinants of the incidence and severity of ventricular arrhythmias in aortic valve disease", Am J Cardiol, 51, pp.1103~1109 (1983)
294. Hochreiter C, "Mitralregurgitation : relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients", Circulation, 73, pp.900~912 (1986)
295. Ross J Jr, "Aortic stenosis", Circulation, 38, pp.61~67 (1968)
296. Sorgato A, "Ventricular arrhythmias in adult aortic stenosis : prevalence, mechanisms, and clinical relevance", Chest, 113, pp.482~491 (1998)
297. Delahaye JP, "Natural history of severe mitral regurgitation", Eur Heart J, 12(Suppl B), pp.5~9 (1991)
298. Grigioni F, "Sudden death in mitral regurgitation due to flail leaflet", J Am Coll Cardiol, 34, pp.2078~2085 (1999)
299. Olafiranye O, "Nonischemic mitral regurgitation : prognostic value of nonsustained ventricular tachycardia after mitral valve surgery", Cardiology, 124, pp.108~115 (2013)
300. Groves P, "Valve disease : Surgery of valve disease : late results and late complications", Heart, 86, pp.715~721 (2001)
301. Blackstone EH, "Death and other time-related events after valve replacement", Circulation, 72, pp.753~767 (1985)
302. Hwang MH, "Comparison of the causes of late death following aortic and mitral valve replacement. VA Co-operative Study on Valvular Heart Disease", J Heart Valve Dis, 3, pp.17~24 (1994)
303. Burke AP, "Causes of sudden cardiac death in patients with replacement valves : an autopsy study", J Heart Valve Dis, 3, pp.10~16 (1994)

관련 논문AI추천